Abstract
We studied 54 idiopathic Parkinson's disease (PD) patients with depressive disorders (DD) to compare the efficacy and the effect of treatment with sertraline in the usual formulation and in the liquid oral concentrate (LOC) formulation. After 6 months of sertraline treatment, the Hamilton Depression Rating Scale and the Montgomery and Asberg Depression Rating Scale showed a decrement (p <0.001, for both formulations). Parkinson's Disease Questionnaire scores improved (p <0.005 for usual formulation and p
Original language | English |
---|---|
Pages (from-to) | 391-395 |
Number of pages | 5 |
Journal | Neurological Sciences |
Volume | 29 |
Issue number | 6 |
DOIs | |
Publication status | Published - 2008 |
Keywords
- Depressive disorders
- Parkinson's disease
- Quality of life
- Sertraline
ASJC Scopus subject areas
- Dermatology
- Clinical Neurology
- Psychiatry and Mental health